Can Money Turn Singapore Into a Biotech Juggernaut?

  title={Can Money Turn Singapore Into a Biotech Juggernaut?},
  author={Dennis Normile},
  pages={1470 - 1473}
BIOMEDICAL SCIENCESINGAPORE-- Singapore is betting that a $2 billion initiative will create the talent pool and business climate needed for a world-class biomedical enterprise. The city-state will need to attract enough rank-and-file life science researchers to achieve a critical mass, and then it will need to keep them long enough to have an impact. But the gamble has already started to pay off. 
From genes to therapeutics: educating the government and the public on biomedical sciences-a Singapore experience.
  • Too Heng Phon
  • Political Science
    BioEssays : news and reviews in molecular, cellular and developmental biology
  • 2003
This review describes how a series of workshops were developed to address the needs and the challenges of educating the public and the government of Singapore on developing Biomedical Sciences as an industry.
Stem Cells in the Media: the Emergence of Public Understanding of a New Technology
The study found that the media during this period were focusing on economic opportunity and prospect rather than ethical issues associated with stem cell research, which differed considerably from the emphasis of media discussion of genetically modified (GM) foods during the previous decade.
A case study on obstacles to the growth of biotechnology
Agricultural Biotechnology in China: Prospects for New Economy Industries in Southeast Asia
Concerns about agricultural productivity appear to have been a key motivation for China to actively participate in the development of biotechnology. The initial motivation was supply-driven with the
Some Small Countries Do It Better: Rapid Growth and Its Causes in Singapore, Finland, and Ireland
This book is an outcome of a series of study visits to Singapore for African policy makers initiated by Jee-Peng Tan in 2005 with support from Tommy Koh in Singapore and Birger Fredriksen, Yaw Ansu,